acetylcysteine has been researched along with Amyotrophic Lateral Sclerosis in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (17.65) | 18.7374 |
1990's | 4 (23.53) | 18.2507 |
2000's | 5 (29.41) | 29.6817 |
2010's | 2 (11.76) | 24.3611 |
2020's | 3 (17.65) | 2.80 |
Authors | Studies |
---|---|
Cheng, J; Deng, H; Deng, S; Fan, K; Gong, L; Guo, Y; Kang, M; Li, H; Xu, H; Yang, H; Yang, Z; Yuan, L; Zheng, W | 1 |
Glasebach, H; Hans, F; Kahle, PJ | 1 |
Alandes, S; Alcácer, J; Banacloche, S; Benlloch, M; Colomer, N; Coronado, JA; Drehmer, E; Estrela, JM; Jihad-Jebbar, A; López-Blanch, R; Marchio, P; Obrador, E; Rivera, P; Salvador, R; Vallés, SL | 1 |
Hadano, S; Hirayama, N; Ikeda, JE; Kanno, T; Tanaka, K; Yanagisawa, Y; Yasutake, K; Yoshii, F | 1 |
Johnson, WM; Mieyal, JJ; Wilson-Delfosse, AL | 1 |
Beretta, S; Carrì, MT; Casciati, A; Ceresa, C; Ferrarese, C; Ferri, A; Mattavelli, L; Sala, G | 1 |
Iłzecka, J; Stelmasiak, Z | 1 |
Cheema, SS; Lopes, EC; Turner, BJ | 1 |
Balakrishnan, S; Carrì, MT; Ebert, S; Goos, M; Jaiswal, MK; Keller, BU; Mitchell, T; Nau, R; Zech, WD | 1 |
Bossuyt, PM; de Jong, JM; Louwerse, ES; Meyjes, FE; Weverling, GJ | 1 |
Bristol, LA; Brown, RH; Hosler, B; Kuncl, RW; Rothstein, JD | 1 |
Bossuyt, PM; de Jong, JM; Louwerse, ES; Timmer, JG; Vyth, A | 1 |
de Jong, JM; Guchelaar, HJ; Haasdijk, E; Holstege, JC; Jaarsma, D | 1 |
Andreassen, OA; Beal, MF; Bush, AI; Dedeoglu, A; Klivenyi, P | 1 |
Küther, G; Lipinski, HG; Struppler, A | 1 |
de Jong, JM; den Hartog Jager, WA; Timmer, JG; Vyth, A | 1 |
Küther, G; Struppler, A | 1 |
1 review(s) available for acetylcysteine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Dysregulation of glutathione homeostasis in neurodegenerative diseases.
Topics: Acetylcysteine; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Brain; Friedreich Ataxia; Glutathione; Homeostasis; Humans; Huntington Disease; Neurodegenerative Diseases; Parkinson Disease | 2012 |
2 trial(s) available for acetylcysteine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Randomized, double-blind, controlled trial of acetylcysteine in amyotrophic lateral sclerosis.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Double-Blind Method; Female; Humans; Male; Middle Aged; Placebos | 1995 |
Survival in patients with amyotrophic lateral sclerosis, treated with an array of antioxidants.
Topics: Acetylcysteine; Administration, Oral; Amyotrophic Lateral Sclerosis; Antioxidants; Capsules; Chelating Agents; Dithioerythritol; Dithiothreitol; Free Radical Scavengers; Gastric Juice; Humans; Injections, Subcutaneous; Methionine; Succimer; Sulfhydryl Reagents; Survival Analysis | 1996 |
14 other study(ies) available for acetylcysteine and Amyotrophic Lateral Sclerosis
Article | Year |
---|---|
Analysis of SOD1 variants in Chinese patients with familial amyotrophic lateral sclerosis.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; East Asian People; Humans; Mutation; Neurodegenerative Diseases; Reactive Oxygen Species; Superoxide Dismutase-1 | 2023 |
Multiple distinct pathways lead to hyperubiquitylated insoluble TDP-43 protein independent of its translocation into stress granules.
Topics: Acetylcysteine; Adenine; Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; Frontotemporal Dementia; Glycogen Synthase Kinase 3 beta; Heat-Shock Proteins; HEK293 Cells; Humans; Indoles; Mutation; Osmotic Pressure; Oxidative Stress; Protein Aggregation, Pathological; Protein Transport; Signal Transduction; Solubility; Sorbitol; Ubiquitination | 2020 |
Nicotinamide Riboside and Pterostilbene Cooperatively Delay Motor Neuron Failure in ALS SOD1
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Antioxidants; Apoptosis; Cytokines; Female; Male; Metabolome; Mice, Inbred C57BL; Mice, Transgenic; Mitochondria; Motor Activity; Motor Neurons; Mutation; NAD; Nerve Degeneration; NF-E2-Related Factor 2; Niacinamide; Oxidation-Reduction; Pyridinium Compounds; Reactive Oxygen Species; Sirtuin 1; Sirtuin 3; Spinal Cord; Stilbenes; Superoxide Dismutase-1; Survival Analysis | 2021 |
A novel small molecule, N-(4-(2-pyridyl)(1,3-thiazol-2-yl))-2-(2,4,6-trimethylphenoxy) acetamide, selectively protects against oxidative stress-induced cell death by activating the Nrf2-ARE pathway: therapeutic implications for ALS.
Topics: Acetamides; Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Antioxidant Response Elements; Apoptosis; Apoptosis Regulatory Proteins; Cell Survival; Drug Evaluation, Preclinical; Enzyme Induction; Enzyme Inhibitors; Female; Free Radical Scavengers; Gene Expression Regulation; Glutamate-Cysteine Ligase; HeLa Cells; Heme Oxygenase-1; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lipid Peroxidation; Male; Metabolic Detoxication, Phase II; Mice; Mice, Transgenic; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Oxidative Stress; Reactive Oxygen Species; Signal Transduction; Thiazoles | 2012 |
Mitochondrial dysfunction due to mutant copper/zinc superoxide dismutase associated with amyotrophic lateral sclerosis is reversed by N-acetylcysteine.
Topics: Acetylcysteine; Adenosine Triphosphate; Amyotrophic Lateral Sclerosis; Blotting, Western; Caspase 3; Caspases; Cell Death; DNA Fragmentation; Fluorescent Antibody Technique; Free Radical Scavengers; Humans; L-Lactate Dehydrogenase; Mitochondria; Mutation; Neuroblastoma; Reactive Oxygen Species; Superoxide Dismutase; Tetrazolium Salts; Thiazoles; Tumor Cells, Cultured | 2003 |
Creatine kinase activity in amyotrophic lateral sclerosis patients.
Topics: Acetylcysteine; Age Factors; Age of Onset; Amyotrophic Lateral Sclerosis; Analysis of Variance; Creatine Kinase; Extremities; Female; Humans; Male; Middle Aged; Sex Factors; Statistics, Nonparametric | 2003 |
Inducible superoxide dismutase 1 aggregation in transgenic amyotrophic lateral sclerosis mouse fibroblasts.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Blotting, Western; Cell Survival; Chelating Agents; Chlorides; Copper; Detergents; Disease Models, Animal; Ditiocarb; Fibroblasts; Humans; Immunohistochemistry; Mice; Mice, Transgenic; Minocycline; Mutation; Oxidative Stress; Paraquat; Peroxynitrous Acid; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Binding; Solubility; Spinal Cord; Superoxide Dismutase; Superoxide Dismutase-1; Zinc Compounds | 2004 |
Expression of a Cu,Zn superoxide dismutase typical for familial amyotrophic lateral sclerosis increases the vulnerability of neuroblastoma cells to infectious injury.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antioxidants; Apoptosis; Bacterial Proteins; Calcium; Caspase 3; Cell Line, Tumor; Cell Survival; Cells, Cultured; Coculture Techniques; Humans; Immunohistochemistry; Lipopeptides; Macrophages; Monocytes; Mutation; Neuroblastoma; Peptides; Streptolysins; Superoxide Dismutase; Toll-Like Receptor 2; Transfection | 2007 |
Chronic inhibition of superoxide dismutase produces apoptotic death of spinal neurons.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Animals; Animals, Newborn; Anti-Anxiety Agents; Antioxidants; Apoptosis; Base Sequence; Benzodiazepines; Biological Transport; Choline O-Acetyltransferase; Chromans; Ditiocarb; Glutamates; Glutamic Acid; Humans; Molecular Sequence Data; Motor Neurons; Nerve Degeneration; Neurotoxins; Oligonucleotides, Antisense; Organ Culture Techniques; Piperazines; Rats; Spinal Cord; Superoxide Dismutase | 1994 |
The antioxidant N-acetylcysteine does not delay disease onset and death in a transgenic mouse model of amyotrophic lateral sclerosis.
Topics: Acetylcysteine; Administration, Oral; Amyotrophic Lateral Sclerosis; Animals; Body Weight; Disease Progression; Free Radical Scavengers; Half-Life; Mice; Mice, Transgenic; Point Mutation; Vitamin E | 1998 |
N-acetyl-L-cysteine improves survival and preserves motor performance in an animal model of familial amyotrophic lateral sclerosis.
Topics: Acetylcysteine; Age Factors; Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Mice; Mice, Transgenic; Motor Activity; Mutation; Superoxide Dismutase; Survival Rate | 2000 |
Therapeutic trials in ALS--the design of a protocol.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Flunarizine; Humans; Manometry; Muscle Contraction; Muscles; Physical Examination; Research Design; Transducers | 1987 |
Attempted treatment of motor neuron disease with N-acetylcysteine and dithiothreitol.
Topics: Acetylcysteine; Amyotrophic Lateral Sclerosis; Dithiothreitol; Drug Evaluation; Drug Hypersensitivity; Drug Therapy, Combination; Humans; Muscular Atrophy; Prednisolone | 1987 |
Therapeutic trial with N-acetylcysteine in amyotrophic lateral sclerosis.
Topics: Acetylcysteine; Adult; Aged; Amyotrophic Lateral Sclerosis; Drug Evaluation; Female; Humans; Male; Middle Aged; Vital Capacity | 1987 |